E1	Age:T1 Numeric-Filter:E2
E2	Eq-Comparison:T2 Operator:T83 Value:T84 Temporal-Unit:T85
E3	Observation:T3 Name:T86 Numeric-Filter:E4
E4	Eq-Comparison:T4 Value:T87 Operator:T88 Value2:T89
E5	Condition:T5 Name:T90
E6	Condition:T6 Name:T91 Polarity:T94
E8	Condition:T8 Name:T92 Polarity:T93
E9	Eq-Comparison:T9 Unit:T95 Value:T96
E12	Modifier:T12 Modifies:T97
E13	Condition:T13 Name:T97 Stage:E9
E14	Modifier:T14 Modifies:T99
E16	Modifier:T16 Modifies:T99
E18	Procedure:T18 Name:T102
E19	Condition:T19 Name:T103
E21	Modifier:T21 Modifies:T103
E22	Procedure:T22 Name:T139
E24	Modifier:T24 Modifies:T105
E25	Procedure:T25 Name:T105
E26	Drug:T26 Name:T106
E27	Negation:T27 Negates:E28
E30	Procedure:T30 Name:T108
E33	Eq-Comparison:T33 Temporal-Recency:T107
E34	Procedure:T34 Name:T109 Temporality:E33
E36	Condition:T36 Name:T111
E38	Procedure:T38 Name:T113 Polarity:T140
E40	Study:T40 
E42	Modifier:T42 Modifies:T114
E43	Observation:T43 Name:T114 Temporality:E41
E44	Condition:T44 Name:T115 Stage:E92
E45	Eq-Comparison:T45 Temporal-Period:T116
E46	Procedure:T46 Name:T117 Temporality:E45
E47	Modifier:T47 Modifies:T117
E49	Modifier:T49 Modifies:T117
E52	Condition:T52 Name:T118 Minimum-Count:E50
E53	Assertion:T53 Asserted:E54
E54	Procedure:T54 
E56	Study:T56 
E59	Risk:T59 Risk-For:E62 Severity:T120
E60	Modifier:T60 Modifies:T121
E62	Observation:T62 Name:T121
E64	Condition:T64 Severity:T123
E66	Condition:T66 Severity:T123
E68	Observation:T68 Name:T125 Numeric-Filter:E69
E69	Eq-Comparison:T69 Operator:T126 Value:T127 Temporal-Unit:T128
E70	Study:T70 Study-Of:E71
E71	Procedure:T71 
E74	Procedure:T74 Name:T130
E75	Condition:T75 Name:T131
E77	Condition:T77 Name:T132
E78	Negation:T78 Negates:E79
E79	Assertion:T79 Asserted:E80
E80	Risk:T80 
E81	Study:T81 
E82	Condition:T82 Name:T135
E51	Modifier:T51 Modifies:T92
E83	Modifier:T136 Modifies:T91
E10	Modifier:T10 Modifies:T97
E84	Condition:T98 Name:T99
E85	Negation:T100 Negates:E18
E86	Assertion:T101 Asserted:E85
E87	Modifier:T137 Modifies:T103
E88	Assertion:T138 Asserted:E22
E23	Assertion:T23 Asserted:E25
E28	Contraindication:T28 Contraindicates:E25
E29	Modifier:T29 Modifies:T108
E89	Modifier:T104 Modifies:T108
E90	Condition:T141 Name:T142
E41	Eq-Comparison:T41 Temporal-Period:T144
E92	Eq-Comparison:T145 Unit:T146 Value:T147
E50	Eq-Comparison:T50 Value:T148
E94	Other:T122 Is-Other:E70
E95	Condition:T149 Name:T129
E72	Contraindication:T72 Contraindicates:E74
T1	Age 25 28	Age
T2	Eq-Comparison 30 49	older than 18 years
T3	Observation 60 64	ECOG
T4	Eq-Comparison 85 88	0-2
T5	Condition 114 119	HNSCC
T6	Condition 125 128	HPV
T8	Condition 148 151	HPV
T9	Eq-Comparison 173 182	Stage III
T12	Modifier 191 194	IVB
T13	Condition 195 200	HNSCC
T14	Modifier 264 276	irresectable
T16	Modifier 288 298	inoperable
T18	Procedure 318 325	surgery
T19	Condition 331 336	Tumor
T21	Modifier 351 363	localization
T22	Procedure 377 394	radiochemotherapy
T24	Modifier 421 442	Simultaneous standard
T25	Procedure 443 455	chemotherapy
T26	Drug 461 470	cisplatin
T27	Negation 483 485	no
T30	Procedure 511 517	Dental
T33	Eq-Comparison 552 557	start
T34	Procedure 561 568	therapy
T36	Condition 589 611	childbearing potential
T38	Procedure 650 663	contraception
T40	Study 836 841	trial
T42	Modifier 935 942	distant
T43	Observation 943 953	metastases
T44	Condition 955 959	UICC
T45	Eq-Comparison 976 984	Previous
T46	Procedure 985 997	radiotherapy
T47	Modifier 1005 1009	head
T49	Modifier 1014 1018	neck
T52	Condition 1038 1048	malignancy
T53	Assertion 1057 1066	likely to
T54	Procedure 1075 1084	treatment
T56	Study 1096 1114	trial intervention
T59	Risk 1196 1200	risk
T60	Modifier 1204 1214	recurrence
T62	Observation 1218 1228	metastases
T63	Encounter 1240 1249	follow-up
T64	Condition 1270 1277	disease
T66	Condition 1281 1298	medical condition
T68	Observation 1304 1319	life expectancy
T69	Eq-Comparison 1323 1341	less than one year
T70	Study 1374 1394	interventional trial
T71	Procedure 1405 1414	treatment
T74	Procedure 1454 1471	radiochemotherapy
T75	Condition 1477 1485	Pregnant
T77	Condition 1489 1498	lactating
T78	Negation 1519 1522	not
T79	Assertion 1523 1530	able to
T80	Risk 1571 1583	consequences
T81	Study 1591 1596	trial
T82	Condition 1602 1627	Nasopharyngeal Carcinomas
T83	Eq-Operator 30 40	older than
T84	Eq-Value 41 43	18
T85	Eq-Temporal-Unit 44 49	years
T86	Observation-Name 60 64	ECOG
T87	Eq-Value 85 86	0
T88	Eq-Operator 86 87	-
T89	Eq-Value 87 88	2
T90	Condition-Name 114 119	HNSCC
T91	Condition-Name 125 128	HPV
T92	Condition-Name 148 151	HPV
T93	Polarity 152 160	positive
T95	Eq-Unit 173 178	Stage
T96	Eq-Value 179 182	III
T99	Condition-Name 244 249	Tumor
T102	Procedure-Name 318 325	surgery
T103	Condition-Name 331 336	Tumor
T105	Procedure-Name 443 455	chemotherapy
T106	Drug-Name 461 470	cisplatin
T108	Procedure-Name 511 517	Dental
T109	Procedure-Name 561 568	therapy
T110	Life-Stage-And-Gender 578 583	women
T111	Condition-Name 589 611	childbearing potential
T112	Life-Stage-And-Gender 616 619	men
T113	Procedure-Name 650 663	contraception
T114	Observation-Name 943 953	metastases
T115	Condition-Name 955 959	UICC
T116	Eq-Temporal-Period 976 984	Previous
T117	Procedure-Name 985 997	radiotherapy
T118	Condition-Name 1038 1048	malignancy
T120	Severity 1183 1195	considerable
T121	Observation-Name 1218 1228	metastases
T123	Severity 1262 1269	Serious
T125	Observation-Name 1304 1319	life expectancy
T126	Eq-Operator 1323 1332	less than
T127	Eq-Value 1333 1336	one
T128	Eq-Temporal-Unit 1337 1341	year
T129	Condition-Name 1398 1404	cancer
T130	Procedure-Name 1454 1471	radiochemotherapy
T131	Condition-Name 1477 1485	Pregnant
T132	Condition-Name 1489 1498	lactating
T133	Life-Stage-And-Gender 1499 1504	women
T135	Condition-Name 1602 1627	Nasopharyngeal Carcinomas
T51	Modifier 161 167	tumors
T94	Polarity 129 137	negative
T136	Modifier 138 144	tumors
T10	Modifier 184 187	IVA
T97	Condition-Name 195 200	HNSCC
T98	Condition 244 249	Tumor
T100	Negation 310 317	refused
T101	Assertion 310 317	refused
T137	Modifier 337 346	extension
T138	Assertion 364 376	suitable for
T139	Procedure-Name 377 394	radiochemotherapy
T23	Assertion 471 481	applicable
T28	Contraindication 486 504	contra-indications
T29	Modifier 535 544	treatment
T104	Modifier 518 529	examination
T107	Eq-Temporal-Recency 552 557	start
T140	Polarity 641 649	adequate
T141	Condition 623 640	reproductive ages
T142	Condition-Name 623 640	reproductive ages
T41	Eq-Comparison 923 931	Presence
T144	Eq-Temporal-Period 923 931	Presence
T145	Eq-Comparison 960 969	stage IVC
T146	Eq-Unit 960 965	stage
T147	Eq-Value 966 969	IVC
T50	Eq-Comparison 1031 1037	Second
T148	Eq-Value 1031 1037	Second
T57	Encounter 1118 1127	follow-up
T122	Other 1364 1373	competing
T149	Condition 1398 1404	cancer
T72	Contraindication 1437 1449	not suitable
A3	Assertion-Type-Value E53 hypothetical
A6	Assertion-Type-Value E79 hypothetical
A7	Eq-Operator-Value T83 GT
A8	Eq-Temporal-Unit-Value T85 year
A9	Eq-Operator-Value T88 BETWEEN
A10	Polarity-Value T93 positive
A11	Life-Stage-And-Gender-Type T110 female
A12	Life-Stage-And-Gender-Type T112 male
A13	Eq-Temporal-Period-Value T116 past
A14	Severity-Value T120 severe
A16	Severity-Value T123 severe
A17	Eq-Operator-Value T126 LT
A18	Eq-Temporal-Unit-Value T128 year
A19	Life-Stage-And-Gender-Type T133 female
A20	Polarity-Value T94 negative
A21	Assertion-Type-Value E86 hypothetical
A22	Assertion-Type-Value E88 hypothetical
A23	Assertion-Type-Value E23 hypothetical
A24	Eq-Temporal-Recency-Value T107 first-time
A25	Polarity-Value T140 normal
A26	Eq-Temporal-Period-Value T144 present
R1	Treatment-For Arg1:E22 Arg2:E19
R2	Using Arg1:E25 Arg2:E26
R3	Equivalent-To Arg1:E44 Arg2:E43
R4	Treatment-For Arg1:E54 Arg2:E52
R5	Caused-By Arg1:E59 Arg2:E52
R6	Treatment-For Arg1:E71 Arg2:E95
R7	If-Then Arg1:T133 Arg2:E77
R8	Caused-By Arg1:E80 Arg2:E81
R9	Or Arg1:E6 Arg2:E8
R10	Or Arg1:E10 Arg2:E12
R11	Or Arg1:E14 Arg2:E16
R12	Or Arg1:E84 Arg2:E85
R13	And Arg1:E87 Arg2:E21
R14	And Arg1:E89 Arg2:E29
R15	Before Arg1:E30 Arg2:E33
R16	And Arg1:T110 Arg2:E36
R17	Or Arg1:E36 Arg2:T112
R18	Or Arg1:E47 Arg2:E49
R19	During Arg1:E54 Arg2:E56
R21	Or Arg1:E60 Arg2:E62
R22	Or Arg1:E64 Arg2:E66
R23	And Arg1:E66 Arg2:E68
R24	Or Arg1:E75 Arg2:E77
R25	And Arg1:T112 Arg2:E90
R20	During Arg1:E62 Arg2:T63	
